Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2024-07-09 00:00:00 ET · period of report 2024-07-08 · accession 0001493152-24-026643 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-09 | 2024-07-08 | ABEO | Alland Leila | Dir | A - Grant | $0.00 | +23.6K | 106.5K | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-08 | A | A | 23,611 | $0.00 | 106,468 | D | — | — | (F1) All of the restricted stock will vest on July 8, 2025. |